More on SILO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (12/3/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Silo Pharma, Inc. (NQ:SILO)
Delayed: 2.10 -0.05 (2.33%)
Prev. Close $2.15  
Open$2.18 
52 Wk High$ 
52 Wk Low$ 
Day High$2.39 
Day Low$2.10 
P/E N/A  
EPS$ 
Volume19,610 

Friends, Peers and Foes (?): CMPS, 2LS, PTLKF, CRCL META (more...)

Sep 9, 2026 09:15 AM Silo Pharma to Highlight Patented Nose-to-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum
Aug 19, 2026 05:20 PM Silo Pharma acquires software assets from Parkview Consulting for stock
Aug 19, 2026 05:17 PM Form 8-K Silo Pharma, Inc. For: Aug 18
Aug 18, 2026 04:15 PM Silo Pharma receives Canadian patent allowance for PTSD drug SPC-15
Aug 18, 2026 04:15 PM Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment
Aug 17, 2026 04:06 PM Form 8-K Silo Pharma, Inc. For: Aug 14
Aug 13, 2026 04:08 PM Form 10-Q Silo Pharma, Inc. For: Jun 30
Aug 13, 2026 10:22 AM Form SCHEDULE 13G/A Silo Pharma, Inc. Filed by: INTRACOASTAL CAPITAL, LLC
Aug 10, 2026 08:15 AM Silo Pharma receives European patent for preventative PTSD treatment
Aug 10, 2026 08:15 AM Silo Pharma Granted European Patent Covering Novel PTSD Therapy
View All Articles

Entities mentioned with SILO

View All Entities